PSILOCYBIN FOR TREATMENT-RESISTANT MAJOR DEPRESSION - RESULTS FROM AN ACADEMIC PHASE 2B RANDOMIZED-CONTROLLED TRIAL

Authors
Category Primary study
Conference63rd Aannual Meeting of the merican College of Neuropsychopharmacology, ACNP 2024
Year 2024
This article has no abstract
Epistemonikos ID: 47de36f14210da1b3207257ddaf027a8a0621f13
First added on: Feb 21, 2026